Altshuler Shaham LTD Glaukos Corp Transaction History

Altshuler Shaham LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$73.06 - $97.7 $33,242 - $44,453	-455 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$70.43 - $97.42 $32,045 - $44,326	455 New	455 $38,000
Q3 2019 Nov 12, 2019	SELL	$58.58 - $83.91 $8,962 - $12,838	-153 Closed	0 $0
Q2 2019 Aug 06, 2019	SELL	$63.59 - $78.71 $8,266 - $10,232	-130 Reduced 45.94%	153 $12,000
Q1 2019 May 15, 2019	BUY	$50.75 - $80.54 $14,362 - $22,792	283 New	283 $22,000

342

46.8M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $7.45B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Altshuler Shaham LTD, based on Form 13F filings with the SEC.

Stay updated on Altshuler Shaham LTD with notifications on news.